✦ LIBER ✦

P1147 OUTCOMES AND COSTS OF TREATING HEPATITIS C WITH PROTEASE INHIBITORS: RESULTS FROM A MULTI-CENTRE STUDY

✍ Scribed by Stahmeyer, J.T.; Rossol, S.; Bert, F.; Abdelfattah, A.M.; Mauss, S.; Heyne, R.; John, C.; Pape, S.; Schober, A.; Teuber, G.; Bruch, H.R.; Zehnter, E.; Hueppe, D.; Pfeiffer-Vornkahl, H.; Alshuth, U.; Krauth, C.

Book ID: 122292717
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 76 KB
Volume: 60
Category: Article
ISSN: 0168-8278
DOI: 10.1016/S0168-8278(14)61307-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Epidemiology, Treatment Outcomes and Cos

Epidemiology, Treatment Outcomes and Costs of Treating Hepatitis C in Routine Care – Results from a Large Multicenter Trial

✍ Stahmeyer, J.T.; Rossol, S.; Bert, F.; Abdelfattah, A.M.; Mauss, S.; Heyne, R.; 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB

P.231 Outcome of decompensated hepatitis

P.231 Outcome of decompensated hepatitis C virus-related cirrhotic patients treated with peg-interferon alpha-2b and ribavirin. A controlled study

✍ A. Iacobellis; M. Siciliano; F. Perri; A. Annicchiarico; G. Leandro; N. Caruso; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 132 KB

Dynamics of resistance mutations to NS3

Dynamics of resistance mutations to NS3 protease inhibitors in a cohort of Brazilian patients chronically infected with hepatitis C virus (genotype 1) treated with pegylated interferon and ribavirin: a prospective longitudinal study

✍ Luísa Hoffmann, Juliene Antonio Ramos, Elizabeth Valentin de Souza… 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 164 KB

257 EFFICACY AND SAFETY OF TEVERELIX LA,

257 EFFICACY AND SAFETY OF TEVERELIX LA, A NEW GNRH ANTAGONIST IN PATIENTS WITH ADVANCED PROSTATE CANCER. RESULTS FROM A PHASE II MULTI-CENTRE, OPEN-LABEL, PILOT STUDY INVESTIGATING AN INITIAL

✍ C. Maclean; F. Larsen; J. Drewe; A. Ulys; D. Kaniušas 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 328 KB